Updated interim analysis of a phase I/Ib study of enfortumab vedotin plus cabozantinib in patients with metastatic urothelial carcinoma.
Year: 2024
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Jacqueline T. Brown, Bassel Nazha, Yuan Liu, Kelsea Lozada, Jeremy D. Smith, Caitlin Hartman, Greta Russler McClintock, Omer Kucuk, Bradley Curtis Carthon, R. Donald Harvey, Mehmet Asim Bilen
Institutions: Winship Cancer Institute, Emory University
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Exelixis
OpenAlex ID: W4400108759
